Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases.
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases.
After decades of pioneering work, our revolutionary platform launched. With our platform, scientists have the ability to precisely deposit epigenetic changes in a locus-specific manner, enabling manipulation of cell phenotype for therapeutic purpose.
Epigenic Therapeutics to present preclinical update of company’s epigenome editing technology for elimination of HBV viral antigens at 2024 annual conference of the European Association for the Study of the Liver
Along with your contribution, we are committed to benefiting patients with wide variety
